Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Techne Cp Cmn (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,365,744
  • Shares Outstanding, K 37,330
  • Annual Sales, $ 499,020 K
  • Annual Income, $ 104,480 K
  • 36-Month Beta 0.79
  • Price/Sales 8.10
  • Price/Cash Flow N/A
  • Price/Book 4.82

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.96 +7.08%
on 06/21/17
119.98 -1.86%
on 06/29/17
+4.86 (+4.31%)
since 06/20/17
3-Month
99.96 +17.80%
on 04/25/17
119.98 -1.86%
on 06/29/17
+15.20 (+14.82%)
since 04/20/17
52-Week
95.68 +23.07%
on 02/07/17
119.98 -1.86%
on 06/29/17
+6.27 (+5.62%)
since 07/20/16

Most Recent Stories

More News
Bio-Techne To Host Conference Call On August 8, 2017 To Announce Fourth Quarter Financial Results

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on August 8, 2017, at 8:00 a.m. CDT to review fourth quarter 2017 financial results.

TECH : 117.55 (+0.51%)
Bio-Techne To Present At The Jefferies 2017 Global Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 7th, 2017, at 3:30...

TECH : 117.55 (+0.51%)
Bio-Techne To Present At The Bank Of America Merrill Lynch Health Care Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch Health Care Conference on Thursday, May...

TECH : 117.55 (+0.51%)
Investor Network: Bio-Techne to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 2, 2017 / Bio-Techne (NASDAQ: TECH) will be discussing their earnings results in their Q3 Earnings Call to be held May 2, 2017 at 9:00 AM Eastern Time.

TECH : 117.55 (+0.51%)
Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2017. The quarterly dividend will be payable...

TECH : 117.55 (+0.51%)
Bio-Techne Releases Third Quarter Fiscal 2017 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2017.

TECH : 117.55 (+0.51%)
Bio-Techne To Present At The Deutsche Bank 42nd Annual Health Care Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Deutsche Bank 42nd Annual Health Care conference on Wednesday, May 3,...

TECH : 117.55 (+0.51%)
DB : 18.48 (+0.54%)
4 Sell-Ranked Drug Stocks Investors Should Avoid Ahead of Earnings

Here is a look at four Sell-Ranked drug stocks with negative earnings ESP that should be avoided ahead of earnings.

TECH : 117.55 (+0.51%)
DRNA : 3.43 (+1.78%)
VYGR : 9.92 (+3.98%)
JNJ : 135.85 (+0.47%)
VRX : 17.45 (+1.16%)
Bio-Techne To Host Conference Call On May 2, 2017 To Announce Third Quarter Financial Results

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on May 2, 2017, at 8:00 a.m. CDT to review third quarter fiscal 2017 financial results.

TECH : 117.55 (+0.51%)
Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult "Ground-state" Stem Cell Technology

Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating,...

TECH : 117.55 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Support & Resistance

2nd Resistance Point 119.00
1st Resistance Point 117.97
Last Price 117.55
1st Support Level 116.35
2nd Support Level 115.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.